Market Value1,712,054,000
Total Holdings70
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RETA / Reata Pharmaceuticals Inc - Class A
CTIC / CTI BioPharma Corp
ALXO / ALX Oncology Holdings Inc.
KDMN / Kadmon Holdings Inc
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
HZNP / Horizon Therapeutics Plc
CLDX / Celldex Therapeutics, Inc.
ICPT / Intercept Pharmaceuticals Inc Call
TVTX / Travere Therapeutics, Inc.
XNCR / Xencor, Inc.
XLRN / Acceleron Pharma Inc
JNCE / Jounce Therapeutics Inc
ALGN / Align Technology, Inc.
OBSV / ObsEva SA.
INZY / Inozyme Pharma, Inc.
QURE / uniQure N.V.
PTCT / PTC Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
VIR / Vir Biotechnology, Inc. Put
SPY / State Street SPDR S&P 500 ETF Trust Put
KURA / Kura Oncology, Inc.
CYT / Cyteir Therapeutics, Inc.
ZYME / Zymeworks Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Put
ALGS / Aligos Therapeutics, Inc.
INSM / Insmed Incorporated
QQQ / Invesco QQQ Trust, Series 1 Put
BPMC / Blueprint Medicines Corporation
BMY / Bristol-Myers Squibb Company Call
YMAB / Y-mAbs Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S
EW / Edwards Lifesciences Corporation
PODD / Insulet Corporation
PDSB / PDS Biotechnology Corporation
IFRX / InflaRx N.V.
AKUS / Akouos Inc
SRRA / Sierra Oncology Inc
ZTS / Zoetis Inc.
RGNX / REGENXBIO Inc.
RHHBY / Roche Holding AG - Depositary Receipt (Common Stock)
GH / Guardant Health, Inc.
FUSN / Fusion Pharmaceuticals Inc.
INBX.V / Inhibrx, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
CMPI / Checkmate Pharmaceuticals Inc
INKT / MiNK Therapeutics, Inc.
REGN / Regeneron Pharmaceuticals, Inc. Put
CCXI / Churchill Capital Corp XI
CCXI / Churchill Capital Corp XI Put
ITCI / Intra-Cellular Therapies, Inc.
VERA / Vera Therapeutics, Inc.
IRTC / iRhythm Holdings, Inc.
HRTX / Heron Therapeutics, Inc.
GRTX / Galera Therapeutics, Inc.
IMTX / Immatics N.V.
ISEE / IVERIC bio Inc Put
PTGX / Protagonist Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc. Call
BIIB / Biogen Inc.
ISEE / IVERIC bio Inc
ABBV / AbbVie Inc.
CYTK / Cytokinetics, Incorporated
FULC / Fulcrum Therapeutics, Inc.
14161H108 / Cardtronics PLC
UTHR / United Therapeutics Corporation
EXEL / Exelixis, Inc.
MRTX / Mirati Therapeutics, Inc.
ACET / Adicet Bio, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
AVTE / Aerovate Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc. Put
NCNA / NuCana plc - Depositary Receipt (Common Stock)
NVCR / NovoCure Limited Call
MRK / Merck & Co., Inc. Call
KRTX / Karuna Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
SYBX / Synlogic, Inc.
UTHR / United Therapeutics Corporation Put
NXTC / NextCure, Inc.
KURA / Kura Oncology, Inc. Call
DXCM / DexCom, Inc.
NTRA / Natera, Inc.
SRPT / Sarepta Therapeutics, Inc.
AGEN / Agenus Inc.
BOLT / Bolt Biotherapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.